Search a Conference through our dedicated search page
This study day is for all health care professionals who are involved directly or indirectly in the care of patients receiving TKI inhibitors as part of cancer treatment. The aim of the day is to provide an update on TKI as treatments, provide an opportunity to network and explore the development of support for this patient population receiving TKI targeted treatments.
